PERSPECTIVE INTERNATIONALE Gestion de la neutropénie fébrile induite par la chimiothérapie parmi des patients adultes en oncologie : recension de la documentation scientifique

Audai Nader Saeed, Nijmeh Al-Atiyyat

Abstract


L’objectif de cette recension de la documentation scientifique est de faire enquête sur les méthodes les plus sécuritaires et appropriées de gestion de la neutropénie fébrile induite par la chimiothérapie. Nous avons mené notre recherche documentaire dans les grandes bases de données électroniques (PUBMED, SPRINGER et WILEY). Nous cherchions des études qui discutent de l’alternative entre les thérapies combinant des facteurs de croissance hématopoïétique et des antibiotiques, d’une part, et les thérapies basées sur les antibiotiques ou les facteurs de croissance hématopoïétique seuls, d’autre part, pour le traitement de la neutropénie fébrile parmi les patients adultes en oncologie. La plupart des études retenues étaient axées sur l’évaluation de patients en oncologie atteints d’une neutropénie fébrile et sur la gestion efficace de leur cas au moyen d’antibiotiques appropriés, et elles soulignaient l’importance de l’utilisation d’antibiotiques et de facteurs de croissance hématopoïétique dans la gestion de la fièvre neutropénique induite par la chimiothérapie. 

Mots clés : neutropénie fébrile, chimiothérapie, gestion, patients en oncologie


Full Text:

PDF

References


Bhardwaj, A.S., & Navada, S.C. (2013). Management of chemotherapy-induced neutropenic fever. Hospital Practice, 41(1), 96–108. doi:10.3810/hp.2013.02.1015

Biswal, S., & Godnaik, C. (2013). Incidence and management of infections in patients with acute leukemia following chemotherapy in general wards. Ecancer Medical Science, 7(310), 1–16. doi:10.3332/ecancer.2013.310

De Naurois, J., Novitzky-Basso, I., Gill, M.J., Marti, F.M., Cullen, M.H., & Roila, F. (2010). Management of febrile neutropenia: ESMO clinical practice guidelines. Annals of Oncology, 21(5), 252–256. doi:10.1093/annonc/mdq196

Doshi, B.D., Pandya, N.M., Shah, C.A., Gupta, A.K., & Makwana, M.V. (2012). Chemotherapy-induced neutropenia in cancer patients with solid tumours in India, Der Pharmacia Lettre, 4(2), 584–590.

Gupta, S., Singh, P.K., Bhatt, M.L., Pant, M.C., Gupta, R., & Negi, M.P. (2010). Efficacy of granulocyte colony stimulating factor as a secondary prophylaxis along with full-dose chemotherapy following a prior cycle of febrile neutropenia. Bioscience Trends, 4(5), 273–278.

Khalafallah, A., Maiwald, M., Hannan, T., Abell, S., Staker, J., & Supperamohan, A. (2012). Early implementation of antifungal therapy in the management of febrile neutropenia is associated with favourable outcome during induction chemotherapy for acute leukaemias. Internal Medicine Journal, 42(2), 131–136.

Mahmood, S., & Tariq, A. (2014). Comparison of antibiotics; granulocyte colony-stimulating factor in children with chemotherapy–induced febrile neutropenia. Professional Medical Journal, 21(4), 667–671.

Mathew, V.V. (2012). Febrile neutropenia. Kerala Nursing Forum, 7, 5–15.

National Chemotherapy Advisory Group (2009). Chemotherapy services in England: Ensuring quality and safety a report from the National Chemotherapy Advisory Group. Retrieved from http://ncat.nhs.uk/sites/default/files/NCAG%20Report.pdf

National Institute for Health and Clinical Excellence (2012). Neutropenic sepsis scope. Retrieved from http://guidance.nice.org.uk/CG/Wave23/11/Scope/pdf/English, NICE, 2012.

Perron, T., Emara, M., & Ahmed, S. (2014). Time to antibiotics and outcomes in cancer patients with febrile neutropenia. BMC Health Services Research, 14(1), 162.

Rosa, R.G., & Goldani, L.Z. (2014). Impact of time to antibiotic administration on mortality in patients with febrile neutropenia: A cohort study. Antimicrobial Agents and Chemotherapy, AAC-02561.

Schouten, H.C., (2006). Neutropenia management. Annals of Oncology, 17. doi:10.1093/annonc/mdl243

Simmons, T. (2012). Prevention and management of neutropenic sepsis in cancer patients. British Medical Journal, 2012, 345.

Villafuerte-Gutierrez, P., Villalon, L., Losa, J.E., & Henriquez-Camacho, C. (2014). Treatment of febrile neutropenia and prophylaxis in hematologic malignancies: A critical review and update. Advances in Hematology, 2014, 1–9. doi:org/10.1155/2014/986938

Weycker, D., Barron, R., Kartashov, A., Legg, J., & Lyman, G.H. (2014). Incidence, treatment, and consequences of chemotherapy-induced febrile neutropenia in the inpatient and outpatient settings. Journal of Oncology Pharmacy Practice, 20(3), 190–198. doi:10.1177/1078155213492450

Wright, J.D., Neugut, A.I., Ananth, C.V., Lewin, S.N., Wilde, E.T., Lu, Y.S., ... & Hershman, D.L. (2013). Deviations from guideline-based therapy for febrile neutropenia in cancer patients and their effect on outcomes. JAMA internal medicine, 173(7), 559–568.


Refbacks

  • There are currently no refbacks.


Bookmark and Share